title: Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity - the two highest quality studies identified do find prostate cancer-related mortality reductions.
authors.affiliation: Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands. m.roobol@erasmusmc.nl
authors.forename: Monique J
authors.initials: MJ
authors.lastname: Roobol
authors.forename: Sigrid
authors.initials: S
authors.lastname: Carlsson
authors.forename: Jonas
authors.initials: J
authors.lastname: Hugosson